Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma.

hepatocellular carcinoma immune checkpoint inhibitors lymphocyte‐rich lymphoepithelial hepatocellular carcinoma programmed cell death ligand 1

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 24 05 2021
revised: 12 08 2021
accepted: 15 08 2021
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 16 9 2021
Statut: epublish

Résumé

Our pathological study of a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.

Identifiants

pubmed: 34522383
doi: 10.1002/ccr3.4764
pii: CCR34764
pmc: PMC8428809
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e04764

Informations de copyright

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors have no conflict of interests.

Références

Hepatology. 2016 Dec;64(6):2038-2046
pubmed: 27359084
World J Gastroenterol. 2015 Sep 28;21(36):10468-74
pubmed: 26420974
Laryngoscope. 1982 May;92(5):510-4
pubmed: 7078327
Case Rep Pathol. 2018 Sep 6;2018:2651716
pubmed: 30258661
J Clin Transl Hepatol. 2021 Apr 28;9(2):265-268
pubmed: 34007809
Immunotherapy. 2017 Sep;9(12):955-961
pubmed: 28971752
Diagn Mol Pathol. 2004 Sep;13(3):183-9
pubmed: 15322431
Medicine (Baltimore). 2018 Oct;97(40):e12548
pubmed: 30290612
Int J Clin Exp Pathol. 2015 Mar 01;8(3):3282-7
pubmed: 26045853
Am J Surg Pathol. 2015 Mar;39(3):304-12
pubmed: 25675010
World J Surg Oncol. 2013 May 04;11:97
pubmed: 23642182
Hepatology. 1998 Feb;27(2):407-14
pubmed: 9462638
Int J Clin Exp Pathol. 2017 Jul 01;10(7):7893-7897
pubmed: 31966638
Medicine (Baltimore). 2017 Dec;96(51):e9416
pubmed: 29390565
Pathol Res Pract. 2009;205(9):648-52
pubmed: 19217218
Transl Lung Cancer Res. 2016 Dec;5(6):720-726
pubmed: 28149767
Chang Gung Med J. 2007 Mar-Apr;30(2):172-7
pubmed: 17596007
Am J Pathol. 2017 Jul;187(7):1438-1444
pubmed: 28500863
Arch Pathol Lab Med. 2014 Sep;138(9):1193-202
pubmed: 25171701
J Pathol. 2019 Oct;249(2):166-172
pubmed: 31168847
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Cancer Immunol Res. 2018 Oct;6(10):1260-1273
pubmed: 30012633
Hepatogastroenterology. 1995 Nov-Dec;42(6):996-1001
pubmed: 8847059
World J Gastroenterol. 2008 Aug 7;14(29):4694-6
pubmed: 18698686
Indian J Pathol Microbiol. 2015 Oct-Dec;58(4):550-3
pubmed: 26549091
Am J Clin Pathol. 1995 Mar;103(3):308-15
pubmed: 7872253
Ann Hepatol. 2017 Jan-Feb 2017;16(1):157-159
pubmed: 28051805
Histopathology. 2000 Dec;37(6):523-9
pubmed: 11122434

Auteurs

Ginji Omori (G)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Takahiro Osuga (T)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Koji Miyanishi (K)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Kota Hamaguchi (K)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Shingo Tanaka (S)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.
Department of Infection Control and Laboratory Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Hiroyuki Ohnuma (H)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Kazuyuki Murase (K)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Kohichi Takada (K)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Minoru Nagayama (M)

Department of Surgery, Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo Japan.

Yasutoshi Kimura (Y)

Department of Surgery, Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo Japan.

Ichiro Takemasa (I)

Department of Surgery, Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo Japan.

Yasuhiro Kikuchi (Y)

Department of Pathology Sapporo Medical University School of Medicine Sapporo Japan.

Toshihiko Torigoe (T)

Department of Pathology Sapporo Medical University School of Medicine Sapporo Japan.

Junji Kato (J)

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Classifications MeSH